Top 100 Contractors in NAICS 325413: In-Vitro Diagnostic Substance Manufacturing, FY2023

Parent companies by net contract obligations Oct 1, 2022 – Sep 30, 2023 Code page on GovTribe

The top 10 won 78% of FY2023 NAICS 325413 contract dollars

Ranking facts

Contract obligations
$1,954,428,952 Net of deobligations, by contracts coded NAICS 325413
Contractors
245 Parent companies with an obligation
Largest contractor
Ihealth Labs Inc. $358 million, 17.4% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $357,750,000
Rank history: not on the FY2021 list, #1 in FY2022 and not on the FY2024–FY2025 lists; unchanged since FY2022.
2 $340,654,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
3 $283,916,739
Rank history: #1 in FY2021, #2 in FY2022, not on the FY2024 list and #4 in FY2025; down 1 since FY2022.
4 $180,233,057
Rank history: #26 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; up 221 since FY2022.
5 $109,204,310
Rank history: #7 in FY2021, #4 in FY2022, #3 in FY2024 and #99 in FY2025; down 1 since FY2022.
6 $86,400,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
7 $73,384,659
Rank history: #47 in FY2021, #34 in FY2022 and not on the FY2024–FY2025 lists; up 27 since FY2022.
8 $61,236,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
9 $59,386,950
Rank history: #10 in FY2021, #59 in FY2022, not on the FY2024 list and #64 in FY2025; up 50 since FY2022.
10 $52,236,000
Rank history: not on the FY2021 list, #8 in FY2022 and not on the FY2024–FY2025 lists; down 2 since FY2022.
11 $42,813,110
Rank history: #4 in FY2021, #5 in FY2022, #1 in FY2024 and #1 in FY2025; down 6 since FY2022.
12 $31,384,584
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
13 $28,728,000
Rank history: #14 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; returned.
14 $28,341,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
15 $26,224,335
Rank history: #8 in FY2021, #12 in FY2022, #4 in FY2024 and not on the FY2025 list; down 3 since FY2022.
16 $23,338,950
Rank history: not on the FY2021 list, #9 in FY2022 and not on the FY2024–FY2025 lists; down 7 since FY2022.
17 $20,557,320
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
18 $16,985,826
Rank history: not on the FY2021 list, #13 in FY2022 and not on the FY2024–FY2025 lists; down 5 since FY2022.
19 $12,032,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
20 $10,798,459
Rank history: #3 in FY2021, #15 in FY2022, #18 in FY2024 and #80 in FY2025; down 5 since FY2022.
21 $6,705,468
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
22 $6,381,930
Rank history: #11 in FY2021, #14 in FY2022, #5 in FY2024 and #19 in FY2025; down 8 since FY2022.
23 $5,888,912
Rank history: not on the FY2021 list, #44 in FY2022 and not on the FY2024–FY2025 lists; up 21 since FY2022.
24 $5,726,532
Rank history: #22 in FY2021, #3 in FY2022, #8 in FY2024 and not on the FY2025 list; down 21 since FY2022.
25 $4,842,765
Rank history: #28 in FY2021, #26 in FY2022, #16 in FY2024 and not on the FY2025 list; up 1 since FY2022.
26
Genabio Diagnostics Inc.
$4,500,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
27 $4,387,477
Rank history: #18 in FY2021, #20 in FY2022, #12 in FY2024 and #9 in FY2025; down 7 since FY2022.
28 $4,287,805
Rank history: #9 in FY2021, #6 in FY2022, #22 in FY2024 and not on the FY2025 list; down 22 since FY2022.
29 $3,948,134
Rank history: #15 in FY2021, #29 in FY2022, #17 in FY2024 and #11 in FY2025; unchanged since FY2022.
30 $3,189,868
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
31 $3,170,119
Rank history: #23 in FY2021, #27 in FY2022, #14 in FY2024 and not on the FY2025 list; down 4 since FY2022.
32 $2,904,365
Rank history: #20 in FY2021, #21 in FY2022, #27 in FY2024 and #16 in FY2025; down 11 since FY2022.
33 $2,741,185
Rank history: #19 in FY2021, #23 in FY2022, #11 in FY2024 and #38 in FY2025; down 10 since FY2022.
34 $2,533,072
Rank history: #25 in FY2021, #32 in FY2022, #43 in FY2024 and not on the FY2025 list; down 2 since FY2022.
35 $2,175,120
Rank history: not on the FY2021 list, #71 in FY2022, #29 in FY2024 and #22 in FY2025; up 36 since FY2022.
36 $1,982,532
Rank history: not on the FY2021 list, #33 in FY2022, #25 in FY2024 and #17 in FY2025; down 3 since FY2022.
37 $1,827,268
Rank history: #41 in FY2021, #31 in FY2022, #73 in FY2024 and not on the FY2025 list; down 6 since FY2022.
38 $1,707,612
Rank history: #42 in FY2021, #46 in FY2022, #23 in FY2024 and #15 in FY2025; up 8 since FY2022.
39 $1,602,319
Rank history: #32 in FY2021, #50 in FY2022, #24 in FY2024 and #20 in FY2025; up 11 since FY2022.
40 $1,451,613
Rank history: #31 in FY2021, #41 in FY2022, #19 in FY2024 and #23 in FY2025; up 1 since FY2022.
41 $1,401,556
Rank history: not on the FY2021–FY2022 lists, #54 in FY2024 and #30 in FY2025; up 133 since FY2022.
42 $1,354,205
Rank history: not on the FY2021–FY2022 lists, not on the FY2024 list and #81 in FY2025; new.
43 $1,340,253
Rank history: not on the FY2021 list, #38 in FY2022, #48 in FY2024 and #76 in FY2025; down 5 since FY2022.
44 $1,262,767
Rank history: #13 in FY2021, #22 in FY2022, #26 in FY2024 and #24 in FY2025; down 22 since FY2022.
45 $1,175,663
Rank history: #35 in FY2021, #81 in FY2022, #28 in FY2024 and not on the FY2025 list; up 36 since FY2022.
46 $1,088,403
Rank history: #16 in FY2021, #35 in FY2022, #52 in FY2024 and #58 in FY2025; down 11 since FY2022.
47 $1,071,923
Rank history: #52 in FY2021, #54 in FY2022, #37 in FY2024 and #14 in FY2025; up 7 since FY2022.
48 $1,060,388
Rank history: #45 in FY2021, #51 in FY2022, #32 in FY2024 and #25 in FY2025; up 3 since FY2022.
49 $988,052
Rank history: not on the FY2021–FY2022 lists, #7 in FY2024 and #5 in FY2025; new.
50 $983,026
Rank history: not on the FY2021 list, #64 in FY2022, #33 in FY2024 and #33 in FY2025; up 14 since FY2022.
51 $979,683
Rank history: #43 in FY2021, #47 in FY2022, #34 in FY2024 and #26 in FY2025; down 4 since FY2022.
52
Ortho-Clinical Diagnostics Singapore PTE. Ltd. Korea Branch 2 awardees, including Ortho-Clinical Diagnostics GMBH
$898,988
Rank history: #46 in FY2021, not on the FY2022 list, #49 in FY2024 and #27 in FY2025; returned.
53 $870,897
Rank history: not on the FY2021 list, #55 in FY2022, #62 in FY2024 and not on the FY2025 list; up 2 since FY2022.
54 $840,600
Rank history: #30 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; up 118 since FY2022.
55 $836,684
Rank history: #29 in FY2021, #36 in FY2022 and not on the FY2024–FY2025 lists; down 19 since FY2022.
56 $833,843
Rank history: #70 in FY2021, #78 in FY2022, #60 in FY2024 and not on the FY2025 list; up 22 since FY2022.
57 $713,909
Rank history: #54 in FY2021, #61 in FY2022, #59 in FY2024 and #46 in FY2025; up 4 since FY2022.
58 $693,898
Rank history: #36 in FY2021, #45 in FY2022, #20 in FY2024 and not on the FY2025 list; down 13 since FY2022.
59 $673,907
Rank history: #44 in FY2021, #60 in FY2022, #42 in FY2024 and #35 in FY2025; up 1 since FY2022.
60 $671,220
Rank history: #67 in FY2021, #58 in FY2022, #40 in FY2024 and not on the FY2025 list; down 2 since FY2022.
61 $665,532
Rank history: #58 in FY2021, #66 in FY2022 and not on the FY2024–FY2025 lists; up 5 since FY2022.
62 $599,842
Rank history: #12 in FY2021, #18 in FY2022, not on the FY2024 list and #66 in FY2025; down 44 since FY2022.
63 $596,175
Rank history: #53 in FY2021, #56 in FY2022, #90 in FY2024 and not on the FY2025 list; down 7 since FY2022.
64 $510,476
Rank history: not on the FY2021 list, #42 in FY2022 and not on the FY2024–FY2025 lists; down 22 since FY2022.
65 $498,768
Rank history: #87 in FY2021, #67 in FY2022, #56 in FY2024 and #78 in FY2025; up 2 since FY2022.
66 $494,360
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 72 since FY2022.
67
Ahlstrom USA Inc.
$474,000
Rank history: #74 in FY2021, #79 in FY2022, #57 in FY2024 and #51 in FY2025; up 12 since FY2022.
68 $459,134
Rank history: #57 in FY2021, #68 in FY2022, #53 in FY2024 and #43 in FY2025; unchanged since FY2022.
69 $438,243
Rank history: #88 in FY2021, #95 in FY2022, #83 in FY2024 and not on the FY2025 list; up 26 since FY2022.
70 $405,792
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 123 since FY2022.
71 $404,384
Rank history: #5 in FY2021, #43 in FY2022, #21 in FY2024 and #7 in FY2025; down 28 since FY2022.
72 $399,993
Rank history: not on the FY2021–FY2022 lists, #39 in FY2024 and not on the FY2025 list; new.
73
Atos Medical Inc.
$381,561
Rank history: #66 in FY2021, not on the FY2022 list, #36 in FY2024 and not on the FY2025 list; returned.
74 $372,235
Rank history: not on the FY2021 list, #80 in FY2022, #61 in FY2024 and not on the FY2025 list; up 6 since FY2022.
75 $371,694
Rank history: #75 in FY2021, #70 in FY2022, #44 in FY2024 and #37 in FY2025; down 5 since FY2022.
76
Tosoh Corporation Through Tosoh Bioscience, Inc.
$364,378
Rank history: #64 in FY2021, #88 in FY2022 and not on the FY2024–FY2025 lists; up 12 since FY2022.
77 $355,312
Rank history: #96 in FY2021, not on the FY2022 list, #82 in FY2024 and #53 in FY2025; up 30 since FY2022.
78
Shabach Services LLC
$347,133
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
79 $339,422
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
80 $336,920
Rank history: #72 in FY2021, #87 in FY2022, #69 in FY2024 and #54 in FY2025; up 7 since FY2022.
81 $312,930
Rank history: #50 in FY2021, #77 in FY2022, not on the FY2024 list and #62 in FY2025; down 4 since FY2022.
82 $306,351
Rank history: #27 in FY2021, #40 in FY2022 and not on the FY2024–FY2025 lists; down 42 since FY2022.
83
Applied Spectral Imaging Ltd.
$304,906
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
84 $284,526
Rank history: #71 in FY2021, #72 in FY2022 and not on the FY2024–FY2025 lists; down 12 since FY2022.
85 $270,038
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 28 since FY2022.
86 $269,841
Rank history: #73 in FY2021, #97 in FY2022, #65 in FY2024 and #61 in FY2025; up 11 since FY2022.
87 $266,525
Rank history: not on the FY2021 list, #89 in FY2022 and not on the FY2024–FY2025 lists; up 2 since FY2022.
88 $247,206
Rank history: not on the FY2021–FY2022 lists, #97 in FY2024 and not on the FY2025 list; new.
89 $241,793
Rank history: not on the FY2021 list, #90 in FY2022, #87 in FY2024 and #56 in FY2025; up 1 since FY2022.
90 $231,319
Rank history: #55 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; up 31 since FY2022.
91
Miraca Holdings Inc. Through Fujirebio US, Inc.
$218,441
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 129 since FY2022.
92 $216,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
93 $206,329
Rank history: not on the FY2021–FY2022 lists, #76 in FY2024 and #77 in FY2025; up 9 since FY2022.
94 $205,715
Rank history: #33 in FY2021, #65 in FY2022, #98 in FY2024 and not on the FY2025 list; down 29 since FY2022.
95 $189,967
Rank history: #94 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; up 22 since FY2022.
96 $189,031
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
97 $179,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
98 $178,319
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
99 $175,701
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 12 since FY2022.
100
Alfresa Holdings Corporation Through Alfresa Corporation
$175,438
Rank history: #100 in FY2021, #57 in FY2022 and not on the FY2024–FY2025 lists; down 43 since FY2022.
Show 75 more

100 of 245 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $2.05 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2023 ran Oct 1, 2022 – Sep 30, 2023. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2022. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2022 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325413 contractors in FY2023?

1. Ihealth Labs Inc. ($358M), 2. Access Bio, Inc. ($341M), 3. Abbott Laboratories ($284M), 4. Quidel Corp ($180M), 5. Roche Holding AG ($109M), 6. Barupon LLC ($86.4M), 7. Cepheid ($73.4M), 8. Azure Medical, Inc. ($61.2M), 9. Orasure Technologies Inc. ($59.4M), 10. Maxim Biomedical, Inc. ($52.2M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work